Elnr.At

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.37, below the industry median of 0.55, and a current ratio of 2.16, indicating strong short-term liquidity. However, net cash is negative after subtracting total debt, signaling potential liquidity risk. Free cash flow of 3.04 million EUR supports operational flexibility, though capital expenditures of -382,570 EUR suggest minimal reinvestment in physical assets.

Profitability metrics show a return on equity of 4.87% and return on assets of 2.91%, both below the industry median of 6.2% and 4.8%, respectively. Operating income of 6.62 million EUR represents a 3.78% margin, which is below the 5.1% median for the specialty chemicals sector. Gross profit of 27.37 million EUR on 175.09 million EUR in revenue yields a 15.63% margin, also below the 17.4% sector median.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of segmentation increases exposure to sector-specific downturns and regional economic shifts. No material geographic revenue breakdown is available in the latest financials.

Revenue growth has not been disclosed in the latest financials, but the company reported 175.09 million EUR in revenue for the period. Analyst estimates suggest a recent actual revenue of 64.82 million EUR, though this may reflect a non-calendar period. No forward-looking guidance is available to assess near-term growth trajectory.

Risk factors include medium liquidity risk due to negative net cash after debt and low dilution risk with no near-term share issuance pressure. No dilution sources are disclosed in the latest filings. The company's capital structure remains stable, with no material adjustments applied to valuation metrics.

Recent events include the latest actual EPS of 0.07 EUR and revenue of 64.82 million EUR, though these figures may not align with calendar periods. No material filings or transcripts are available in the latest data.